The purpose of the study is to determine the effectiveness of wild blueberries on cardiovascular health, cognitive function, and gut microbiota composition in non-Hispanic Black and White adults with elevated blood pressure.
Hypertension (HTN), or high blood pressure (BP) is a major modifiable risk factor for heart disease, the leading cause of death worldwide. In the U.S., 121.5 million adults have high BP and only 25% have their BP under control. The 2022 Heart Disease and Stroke Statistics indicated that the incidence of high BP was higher among non-Hispanic Black (NHB) compared to non-Hispanic White (NHW) adults. Berries are rich in fiber and phytochemicals and have several health benefits. A 14-year follow-up of the Nurses' Health Study I and II and the Health Professional Follow-Up Study revealed a significant reduction in the risk of HTN (8%) among individuals in the highest quintile of anthocyanin intake compared to the lowest quintile. Blueberries are rich in fiber and phytochemicals that may be responsible for their health benefits. Studies have shown that daily blueberry consumption improves heart, cognitive, and intestinal health in different populations. Yet, a comprehensive study exploring and comparing the effectiveness of wild blueberries for cardiovascular, intestinal, and cognitive function parameters and their association in NHB and NHW adults with high BP has not been conducted to date. Thus, the overall objective of this timely study is to determine and compare the effectiveness of a freeze-dried wild blueberry intervention on cardiovascular and gut health in NHB and NHW adults with high BP and assess whether these health benefits are associated with improvements in memory and other important thinking abilities for productivity and quality of life. Therefore, this 8-week randomized, placebo-controlled parallel-arm clinical trial aims to assess whether daily consumption of 22 g of freeze-dried wild blueberry powder improves gut, cardiovascular, and cognitive function in NHB and NHW adults with elevated blood pressure and stage 1 hypertension. Investigators hypothesize that daily consumption of wild blueberries will improve cardiovascular parameters, gut dysbiosis, and cognitive function. To test these hypotheses, the following specific aims are proposed. To investigate whether daily consumption of 22 g of freeze-dried wild blueberry powder: * Reduces BP, improves endothelial function, arterial stiffness, and microcirculation. * Favorably modulates gut microbiota composition. * Improves cognitive function (verbal memory and executive functions \[inhibition, working memory, cognitive flexibility\]). * Improves serum markers of oxidative stress and inflammation. Additionally, investigators will also explore whether changes in the gut microbiota are associated with changes in cardiometabolic and cognitive function outcomes and whether changes in cardiometabolic outcomes are associated with changes in cognitive function parameters globally and within each race.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Enrollment
80
Daily consumption of 22 g of freeze-dried wild blueberry freeze-dried powder for 8 weeks
Daily consumption of 22 g of freeze-dried macronutrient-matched placebo powder for 8 weeks
Georgia State University
Atlanta, Georgia, United States
RECRUITINGAmbulatory Blood Pressure
Assessment of whole-day ambulatory blood pressure during daytime and nighttime periods.
Time frame: Baseline, 4 weeks, and 8 weeks
Pulse Wave Velocity
Arterial Stiffness will be measured by pulse wave velocity using SphygmCor
Time frame: Baseline, 4 weeks, and 8 weeks
Reactive Hyperemia Index
Assessment of endothelial function in response to increased shear stress using EndoPAT2000
Time frame: Baseline, 4 weeks, and 8 weeks
Gut Microbiota Composition
Analysis of stool sample for determination of absolute levels of bacteria and relative species composition
Time frame: Baseline, 4 weeks, and 8 weeks
Global Cognitive Ability
Measured using NIH Toolbox Picture Vocabulary and Oral Reading Recognition test
Time frame: Screening
Performance Validity
Assessed using Rey 15
Time frame: Baseline, 4 weeks, and 8 weeks
Verbal Memory & Recognition
Measured using Rey Auditory Verbal Learning Test with appropriate alternate forms
Time frame: Baseline, 4 weeks, and 8 weeks
Cognitive Inhibition
Assessed using Delis-Kaplan Executive Function System Trails and Verbal Fluency Switching
Time frame: Baseline, 4 weeks, and 8 weeks
Working Memory
Measured using Digit Span and NIH Toolbox List Sorting
Time frame: Baseline, 4 weeks, and 8 weeks
Processing Speed
Measured using NIH Toolbox Pattern Comparison and Oral Symbol Digit tests
Time frame: Baseline, 4 weeks, and 8 weeks
Associative Memory
Measured using NIH Toolbox Face Name Associative Memory Exam and Face Name Associative Memory Exam Delay tests
Time frame: Baseline, 4 weeks, and 8 weeks
Attention
Assessed using Wechsler Adult Intelligence Scale - IV and Rey Auditory Verbal Learning Test Trial 1.
Time frame: Baseline, 4 weeks, and 8 weeks
Problem-Solving
Assessed using NIH Toolbox Visual Reasoning
Time frame: Baseline, 4 weeks, and 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.